MacroGenics Debt to Equity Ratio 2012-2020 | MGNX

Current and historical debt to equity ratio values for MacroGenics (MGNX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. MacroGenics debt/equity for the three months ending March 31, 2020 was 0.14.
MacroGenics Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2020-03-31 $0.03B $0.19B 0.14
2019-12-31 $0.03B $0.23B 0.12
2019-09-30 $0.03B $0.26B 0.11
2019-06-30 $0.02B $0.29B 0.08
2019-03-31 $0.03B $0.32B 0.08
2018-12-31 $0.00B $0.24B 0.00
2018-09-30 $0.00B $0.28B 0.00
2018-06-30 $0.00B $0.31B 0.00
2018-03-31 $0.00B $0.25B 0.00
2017-12-31 $0.00B $0.30B 0.00
2017-09-30 $0.00B $0.19B 0.00
2017-06-30 $0.00B $0.23B 0.00
2017-03-31 $0.00B $0.24B 0.00
2016-12-31 $0.00B $0.27B 0.00
2016-09-30 $0.00B $0.30B 0.00
2016-06-30 $0.00B $0.33B 0.00
2016-03-31 $0.00B $0.29B 0.01
2015-12-31 $0.00B $0.31B 0.01
2015-09-30 $0.00B $0.34B 0.01
2015-06-30 $0.00B $0.21B 0.02
2015-03-31 $0.01B $0.23B 0.03
2014-12-31 $0.01B $0.12B 0.05
2014-09-30 $0.01B $0.14B 0.05
2014-06-30 $0.01B $0.14B 0.05
2014-03-31 $0.01B $0.15B 0.05
2013-12-31 $0.01B $0.08B 0.10
2013-09-30 $0.01B $-0.01B -1.20
2013-06-30 $0.01B $-0.01B -0.63
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B 0.00
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2011-12-31 $0.01B $-0.02B -0.49
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.945B $0.064B
MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $167.899B 29.12
Medtronic (MDT) Ireland $132.114B 21.48
Stryker (SYK) United States $73.365B 23.81
Boston Scientific (BSX) United States $53.161B 24.99
Baxter (BAX) United States $45.654B 0.00
Lonza Group Ag (LZAGY) Switzerland $36.676B 0.00
Terumo (TRUMY) Japan $29.978B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $28.400B 0.00
Zimmer Biomet Holdings (ZBH) United States $26.077B 16.41
ResMed (RMD) United States $23.266B 36.72
Smith & Nephew SNATS (SNN) United Kingdom $17.849B 0.00
Sunny Optical Technology (SNPTF) China $14.583B 0.00
Bio-Rad Laboratories (BIO) United States $14.566B 66.31
Insulet (PODD) United States $11.896B 1178.56
DiaSorin S.p.A (DSRLF) Italy $10.630B 0.00
Perrigo (PRGO) Ireland $7.466B 13.36
Quidel (QDEL) United States $7.350B 57.76
Shandong Weigao Medical Polymer (SHWGF) China $7.281B 0.00
Hill-Rom Holdings (HRC) United States $6.767B 19.08
William Demant Holdings (WILYY) Denmark $6.670B 0.00
GN STORE NORD (GNNDY) Denmark $6.590B 0.00
Canopy Growth (CGC) Canada $6.093B 0.00
Haemonetics (HAE) United States $5.517B 33.14
ICU Medical (ICUI) United States $4.159B 30.34
GW Pharmaceuticals (GWPH) United Kingdom $3.796B 0.00
Neogen (NEOG) United States $3.754B 63.59
Agios Pharmaceuticals (AGIO) United States $3.564B 0.00
Envista Holdings (NVST) United States $3.366B 0.00
NuVasive (NUVA) United States $3.106B 24.94
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.909B 0.00
National Vision Holdings (EYE) United States $2.150B 37.19
TG Therapeutics (TGTX) United States $2.055B 0.00
AtriCure (ATRC) United States $1.916B 0.00
Aurora Cannabis (ACB) Canada $1.428B 0.00
Cardiovascular Systems (CSII) United States $1.366B 0.00
NanoString Technologies (NSTG) United States $1.152B 0.00
Aphria (APHA) Canada $1.130B 0.00
Phibro Animal Health (PAHC) United States $1.060B 21.13
Cerus (CERS) United States $1.020B 0.00
InMode (INMD) Israel $0.937B 19.80
OraSure Technologies (OSUR) United States $0.902B 181.75
PetIQ (PETQ) United States $0.871B 25.15
Omeros (OMER) United States $0.811B 0.00
Quanterix (QTRX) United States $0.781B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.735B 0.00
VAREX IMAGING (VREX) United States $0.734B 18.21
Eagle Pharmaceuticals (EGRX) United States $0.702B 50.26
Meridian Bioscience (VIVO) United States $0.662B 24.93
Zynex (ZYXI) United States $0.644B 64.67
Vapotherm (VAPO) United States $0.567B 0.00
Lantheus Holdings (LNTH) United States $0.546B 10.98
LeMaitre Vascular (LMAT) United States $0.543B 30.91
Surmodics (SRDX) United States $0.503B 60.62
Owens & Minor (OMI) United States $0.500B 13.22
Repro-Med Systems (KRMD) United States $0.402B 337.33
Cytosorbents (CTSO) United States $0.370B 0.00
Utah Medical Products (UTMD) United States $0.362B 26.32
BioLife Solutions (BLFS) United States $0.336B 149.54
Viemed Healthcare (VMD) United States $0.321B 28.72
Organigram Holdings (OGI) Canada $0.306B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.283B 0.00
HEXO (HEXO) $0.258B 0.00
Female Health (VERU) United States $0.247B 0.00
Chimerix (CMRX) United States $0.193B 0.00
Chembio Diagnostics (CEMI) United States $0.169B 0.00
Evolus (EOLS) United States $0.154B 0.00
Fonar (FONR) United States $0.154B 13.66
Bovie Medical (APYX) United States $0.152B 0.00
Rockwell Medical (RMTI) United States $0.148B 0.00
Exagen (XGN) United States $0.146B 0.00
Surface Oncology (SURF) United States $0.145B 0.00
United Health Products (UEEC) United States $0.134B 0.00
Liberty Health Sciences (LHSIF) Canada $0.127B 0.00
MTech Acquisition (KERN) United States $0.123B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.109B 0.00
Brainsway (BWAY) Israel $0.084B 0.00
Wound Management Technologies (SMTI) United States $0.074B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.073B 0.00
United-Guardian (UG) United States $0.072B 16.77
Nephros (NEPH) United States $0.070B 0.00
Capricor Therapeutics (CAPR) United States $0.066B 0.00
GUARDION HEALTH (GHSI) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
Trinity Biotech (TRIB) Ireland $0.030B 0.00
NF Energy Saving (BIMI) China $0.025B 0.00
FSD PHARMA INC (HUGE) Canada $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.014B 0.00
Senestech (SNES) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00